These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15287932)

  • 21. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
    Hodson L; Bickerton AS; McQuaid SE; Roberts R; Karpe F; Frayn KN; Fielding BA
    Diabetes; 2007 Oct; 56(10):2433-41. PubMed ID: 17601988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acarbose (glucobai) effects on lipid metabolism in patients with non-insulin dependent diabetes mellitus].
    Rosliakova LV; Roĭtman AP; Ametov AS; Dolgov VV
    Ter Arkh; 2000; 72(8):54-6. PubMed ID: 11019430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N; Burkert A; Haak T
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
    Schmoelzer I; de Campo A; Pressl H; Stelzl H; Dittrich P; Oettl K; Wascher TC
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):176-81. PubMed ID: 15789278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationship between insulin resistance and postprandial abnormal serum triglyceride metabolism in essential hypertension].
    Lin J; Peng F; Zeng K; Wu K; Kang Q
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1521-4. PubMed ID: 12609058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
    Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
    Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial.
    Zhou J; Deng Z; Lu J; Li H; Zhang X; Peng Y; Mo Y; Bao Y; Jia W
    Diabetes Technol Ther; 2015 Apr; 17(4):229-34. PubMed ID: 25781235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?
    Kriketos A; Milner KL; Denyer G; Campbell L
    Eur J Clin Invest; 2005 Feb; 35(2):117-25. PubMed ID: 15667583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting triglyceride is a major determinant of postprandial triglyceride response in postmenopausal women.
    Hwu CM; Lin MW; Liou TL; Hsiao LC; Liang KW; Tsai TT; Ho LT
    Menopause; 2008; 15(1):150-6. PubMed ID: 17549035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C; Hofmann U; Paulwitz O
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
    Masding MG; Stears AJ; Burdge GC; Wootton SA; Sandeman DD
    Diabet Med; 2006 Jul; 23(7):768-74. PubMed ID: 16842482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
    Johanson EH; Jansson PA; Gustafson B; Sandqvist M; Taskinen MR; Smith U; Axelsen M
    Diabetes Metab Res Rev; 2005; 21(4):376-81. PubMed ID: 15724236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency.
    Agren JJ; Hallikainen M; Vidgren H; Miettinen TA; Gylling H
    Clin Chim Acta; 2006 Apr; 366(1-2):309-15. PubMed ID: 16364276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the alpha-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs.
    Robertson J; Nelson R; Kass P; Neal L
    Am J Vet Res; 1999 May; 60(5):541-5. PubMed ID: 10328421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.